Stran & Company, Inc. (SWAG) Competitors

$1.88 -0.09 (-4.57%)

Closing price 05/19/2026 04:00 PM Eastern

Extended Trading

$1.87 -0.01 (-0.53%)

As of 05/19/2026 04:10 PM Eastern

SWAG vs. AMWL, ATLN, NXTT, MXCT, and SCOR

Should you buy Stran & Company, Inc. stock or one of its competitors? MarketBeat compares Stran & Company, Inc. with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Stran & Company, Inc. include American Well (AMWL), Atlantic International (ATLN), Next Technology (NXTT), MaxCyte (MXCT), and comScore (SCOR). These companies are all part of the "business services" industry.

How does Stran & Company, Inc. compare to American Well?

American Well (NYSE:AMWL) and Stran & Company, Inc. (NASDAQ:SWAG) are both small-cap business services companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, dividends, media sentiment, risk, valuation, profitability, analyst recommendations and institutional ownership.

American Well has a beta of 1.52, indicating that its share price is 52% more volatile than the broader market. Comparatively, Stran & Company, Inc. has a beta of 1.89, indicating that its share price is 89% more volatile than the broader market.

American Well presently has a consensus price target of $7.30, suggesting a potential downside of 6.77%. Given American Well's stronger consensus rating and higher possible upside, equities analysts clearly believe American Well is more favorable than Stran & Company, Inc..

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
American Well	1 Sell rating(s)	4 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Stran & Company, Inc.	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, Stran & Company, Inc. had 2 more articles in the media than American Well. MarketBeat recorded 4 mentions for Stran & Company, Inc. and 2 mentions for American Well. American Well's average media sentiment score of 0.85 beat Stran & Company, Inc.'s score of 0.83 indicating that American Well is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
American Well	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Stran & Company, Inc.	0 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Stran & Company, Inc. has lower revenue, but higher earnings than American Well. American Well is trading at a lower price-to-earnings ratio than Stran & Company, Inc., indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
American Well	$249.32M	0.52	-$95.70M	-$5.42	N/A
Stran & Company, Inc.	$116.19M	0.30	-$750K	$0.01	188.00

Stran & Company, Inc. has a net margin of 0.33% compared to American Well's net margin of -37.02%. Stran & Company, Inc.'s return on equity of 1.26% beat American Well's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
American Well	-37.02%	-32.11%	-24.12%
Stran & Company, Inc.	0.33%	1.26%	0.73%

56.1% of American Well shares are owned by institutional investors. Comparatively, 56.4% of Stran & Company, Inc. shares are owned by institutional investors. 12.8% of American Well shares are owned by insiders. Comparatively, 49.6% of Stran & Company, Inc. shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Summary

Stran & Company, Inc. beats American Well on 10 of the 16 factors compared between the two stocks.

How does Stran & Company, Inc. compare to Atlantic International?

Stran & Company, Inc. (NASDAQ:SWAG) and Atlantic International (NASDAQ:ATLN) are both small-cap business services companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, analyst recommendations, media sentiment, profitability, dividends, earnings, risk and institutional ownership.

Stran & Company, Inc. has a beta of 1.89, indicating that its share price is 89% more volatile than the broader market. Comparatively, Atlantic International has a beta of 0.74, indicating that its share price is 26% less volatile than the broader market.

56.4% of Stran & Company, Inc. shares are held by institutional investors. 49.6% of Stran & Company, Inc. shares are held by company insiders. Comparatively, 13.6% of Atlantic International shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Stran & Company, Inc. has a net margin of 0.33% compared to Atlantic International's net margin of -13.64%. Stran & Company, Inc.'s return on equity of 1.26% beat Atlantic International's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Stran & Company, Inc.	0.33%	1.26%	0.73%
Atlantic International	-13.64%	N/A	-54.43%

Stran & Company, Inc. has higher earnings, but lower revenue than Atlantic International. Atlantic International is trading at a lower price-to-earnings ratio than Stran & Company, Inc., indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Stran & Company, Inc.	$116.19M	0.30	-$750K	$0.01	188.00
Atlantic International	$435.88M	0.23	-$59.43M	-$1.09	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Stran & Company, Inc.	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Atlantic International	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	1 Strong Buy rating(s)	2.33

In the previous week, Stran & Company, Inc. had 4 more articles in the media than Atlantic International. MarketBeat recorded 4 mentions for Stran & Company, Inc. and 0 mentions for Atlantic International. Stran & Company, Inc.'s average media sentiment score of 0.83 beat Atlantic International's score of 0.00 indicating that Stran & Company, Inc. is being referred to more favorably in the media.

Company	Overall Sentiment
Stran & Company, Inc.	Positive
Atlantic International	Neutral

Summary

Stran & Company, Inc. beats Atlantic International on 12 of the 15 factors compared between the two stocks.

How does Stran & Company, Inc. compare to Next Technology?

Stran & Company, Inc. (NASDAQ:SWAG) and Next Technology (NASDAQ:NXTT) are both small-cap business services companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, analyst recommendations, media sentiment, institutional ownership, risk, valuation, profitability and dividends.

Next Technology has lower revenue, but higher earnings than Stran & Company, Inc.. Next Technology is trading at a lower price-to-earnings ratio than Stran & Company, Inc., indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Stran & Company, Inc.	$116.19M	0.30	-$750K	$0.01	188.00
Next Technology	$11.61M	9.46	$143.16M	-$74.80	N/A

Stran & Company, Inc. has a beta of 1.89, meaning that its share price is 89% more volatile than the broader market. Comparatively, Next Technology has a beta of 6.14, meaning that its share price is 514% more volatile than the broader market.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Stran & Company, Inc.	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Next Technology	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Stran & Company, Inc. has a net margin of 0.33% compared to Next Technology's net margin of 0.00%. Stran & Company, Inc.'s return on equity of 1.26% beat Next Technology's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Stran & Company, Inc.	0.33%	1.26%	0.73%
Next Technology	N/A	-30.01%	-26.15%

In the previous week, Stran & Company, Inc. had 3 more articles in the media than Next Technology. MarketBeat recorded 4 mentions for Stran & Company, Inc. and 1 mentions for Next Technology. Stran & Company, Inc.'s average media sentiment score of 0.83 beat Next Technology's score of 0.00 indicating that Stran & Company, Inc. is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Stran & Company, Inc.	0 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Next Technology	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

56.4% of Stran & Company, Inc. shares are owned by institutional investors. Comparatively, 2.7% of Next Technology shares are owned by institutional investors. 49.6% of Stran & Company, Inc. shares are owned by insiders. Comparatively, 52.2% of Next Technology shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Summary

Stran & Company, Inc. beats Next Technology on 9 of the 13 factors compared between the two stocks.

How does Stran & Company, Inc. compare to MaxCyte?

MaxCyte (NASDAQ:MXCT) and Stran & Company, Inc. (NASDAQ:SWAG) are both small-cap business services companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, institutional ownership, earnings, risk, dividends, valuation, analyst recommendations and media sentiment.

Stran & Company, Inc. has higher revenue and earnings than MaxCyte. MaxCyte is trading at a lower price-to-earnings ratio than Stran & Company, Inc., indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
MaxCyte	$33.03M	3.37	-$44.63M	-$0.37	N/A
Stran & Company, Inc.	$116.19M	0.30	-$750K	$0.01	188.00

Stran & Company, Inc. has a net margin of 0.33% compared to MaxCyte's net margin of -121.16%. Stran & Company, Inc.'s return on equity of 1.26% beat MaxCyte's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
MaxCyte	-121.16%	-20.03%	-17.14%
Stran & Company, Inc.	0.33%	1.26%	0.73%

68.8% of MaxCyte shares are held by institutional investors. Comparatively, 56.4% of Stran & Company, Inc. shares are held by institutional investors. 4.1% of MaxCyte shares are held by insiders. Comparatively, 49.6% of Stran & Company, Inc. shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

MaxCyte has a beta of 1.37, indicating that its share price is 37% more volatile than the broader market. Comparatively, Stran & Company, Inc. has a beta of 1.89, indicating that its share price is 89% more volatile than the broader market.

In the previous week, Stran & Company, Inc. had 1 more articles in the media than MaxCyte. MarketBeat recorded 4 mentions for Stran & Company, Inc. and 3 mentions for MaxCyte. Stran & Company, Inc.'s average media sentiment score of 0.83 beat MaxCyte's score of 0.23 indicating that Stran & Company, Inc. is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
MaxCyte	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Stran & Company, Inc.	0 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

MaxCyte currently has a consensus price target of $5.50, suggesting a potential upside of 428.85%. Given MaxCyte's stronger consensus rating and higher probable upside, analysts plainly believe MaxCyte is more favorable than Stran & Company, Inc..

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
MaxCyte	1 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.20
Stran & Company, Inc.	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

Stran & Company, Inc. beats MaxCyte on 11 of the 16 factors compared between the two stocks.

How does Stran & Company, Inc. compare to comScore?

Stran & Company, Inc. (NASDAQ:SWAG) and comScore (NASDAQ:SCOR) are both small-cap business services companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, analyst recommendations, earnings, valuation, profitability, dividends, media sentiment and institutional ownership.

Stran & Company, Inc. has higher earnings, but lower revenue than comScore. comScore is trading at a lower price-to-earnings ratio than Stran & Company, Inc., indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Stran & Company, Inc.	$116.19M	0.30	-$750K	$0.01	188.00
comScore	$357.47M	0.27	-$10M	$2.34	2.75

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Stran & Company, Inc.	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
comScore	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

comScore has a net margin of 24.81% compared to Stran & Company, Inc.'s net margin of 0.33%. comScore's return on equity of 230.75% beat Stran & Company, Inc.'s return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Stran & Company, Inc.	0.33%	1.26%	0.73%
comScore	24.81%	230.75%	23.84%

56.4% of Stran & Company, Inc. shares are owned by institutional investors. Comparatively, 42.2% of comScore shares are owned by institutional investors. 49.6% of Stran & Company, Inc. shares are owned by company insiders. Comparatively, 11.1% of comScore shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

In the previous week, comScore had 4 more articles in the media than Stran & Company, Inc.. MarketBeat recorded 8 mentions for comScore and 4 mentions for Stran & Company, Inc.. Stran & Company, Inc.'s average media sentiment score of 0.83 beat comScore's score of -0.31 indicating that Stran & Company, Inc. is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Stran & Company, Inc.	0 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
comScore	0 Very Positive mention(s)	1 Positive mention(s)	5 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Stran & Company, Inc. has a beta of 1.89, indicating that its share price is 89% more volatile than the broader market. Comparatively, comScore has a beta of 1.06, indicating that its share price is 6% more volatile than the broader market.

Summary

comScore beats Stran & Company, Inc. on 8 of the 15 factors compared between the two stocks.

Get Stran & Company, Inc. News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SWAG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

SWAG vs. The Competition

Export

Metric	Stran & Company, Inc.	ADVERTISING/MKTG SVCS Industry	Business Sector	NASDAQ Exchange
Market Cap	$36.98M	$2.05B	$6.49B	$12.23B
Dividend Yield	N/A	4.18%	3.15%	5.32%
P/E Ratio	188.19	26.72	29.17	25.05
Price / Sales	0.30	83.75	399.47	72.69
Price / Cash	100.08	11.31	22.70	54.25
Price / Book	1.13	17.46	6.75	6.83
Net Income	-$750K	$17.81M	$204.94M	$335.69M
7 Day Performance	8.05%	-5.77%	-1.52%	-2.15%
1 Month Performance	9.94%	-4.92%	-5.27%	-2.47%
1 Year Performance	50.40%	306.19%	28.34%	27.13%

Stran & Company, Inc. Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
SWAG Stran & Company, Inc.	1.2632 of 5 stars	$1.88 -4.6%	N/A	+51.6%	$36.98M	$116.19M	188.19	70	Earnings Report Short Interest Decrease
AMWL American Well	2.2357 of 5 stars	$7.72 -0.2%	$7.30 -5.4%	+7.4%	$127.94M	$249.32M	N/A	1,040
ATLN Atlantic International	0.4421 of 5 stars	$1.54 +1.3%	N/A	-51.3%	$120.62M	$435.88M	N/A	7	Gap Down
NXTT Next Technology	0.5961 of 5 stars	$1.45 -5.2%	N/A	-99.6%	$116.68M	$11.61M	N/A	8	News Coverage
MXCT MaxCyte	2.7262 of 5 stars	$1.09 +6.9%	$5.50 +404.6%	-54.4%	$109.26M	$33.03M	N/A	80	Earnings Report Analyst Upgrade High Trading Volume

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:SWAG) was last updated on 5/20/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Stran & Company, Inc. (SWAG) Competitors

SWAG vs. AMWL, ATLN, NXTT, MXCT, and SCOR

How does Stran & Company, Inc. compare to American Well?

Summary

How does Stran & Company, Inc. compare to Atlantic International?

Summary

How does Stran & Company, Inc. compare to Next Technology?

Summary

How does Stran & Company, Inc. compare to MaxCyte?

Summary

How does Stran & Company, Inc. compare to comScore?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SWAG vs. The Competition

Stran & Company, Inc. Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Stran & Company, Inc. (SWAG) Competitors

SWAG vs. AMWL, ATLN, NXTT, MXCT, and SCOR

How does Stran & Company, Inc. compare to American Well?

Which has more risk & volatility, AMWL or SWAG?

Do analysts rate AMWL or SWAG?

Does the media favor AMWL or SWAG?

Which has higher earnings & valuation, AMWL or SWAG?

Is AMWL or SWAG more profitable?

Do insiders & institutionals hold more shares of AMWL or SWAG?

Summary

How does Stran & Company, Inc. compare to Atlantic International?

Which has more volatility and risk, SWAG or ATLN?

Do institutionals and insiders hold more shares of SWAG or ATLN?

Is SWAG or ATLN more profitable?

Which has stronger valuation and earnings, SWAG or ATLN?

Do analysts prefer SWAG or ATLN?

Does the media refer more to SWAG or ATLN?

Summary

How does Stran & Company, Inc. compare to Next Technology?

Which has preferable earnings & valuation, SWAG or NXTT?

Which has more risk & volatility, SWAG or NXTT?

Do analysts recommend SWAG or NXTT?

Is SWAG or NXTT more profitable?

Does the media prefer SWAG or NXTT?

Do insiders & institutionals believe in SWAG or NXTT?

Summary

How does Stran & Company, Inc. compare to MaxCyte?

Which has preferable earnings and valuation, MXCT or SWAG?

Is MXCT or SWAG more profitable?

Do institutionals and insiders have more ownership in MXCT or SWAG?

Which has more volatility & risk, MXCT or SWAG?

Does the media favor MXCT or SWAG?

Do analysts recommend MXCT or SWAG?

Summary

How does Stran & Company, Inc. compare to comScore?

Which has higher valuation and earnings, SWAG or SCOR?

Do analysts prefer SWAG or SCOR?

Is SWAG or SCOR more profitable?

Do institutionals and insiders believe in SWAG or SCOR?

Does the media favor SWAG or SCOR?

Which has more risk & volatility, SWAG or SCOR?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SWAG vs. The Competition

Stran & Company, Inc. Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools